Verne A. Ray

1.2k total citations
27 papers, 935 citations indexed

About

Verne A. Ray is a scholar working on Cancer Research, Molecular Biology and Plant Science. According to data from OpenAlex, Verne A. Ray has authored 27 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 7 papers in Plant Science. Recurrent topics in Verne A. Ray's work include Carcinogens and Genotoxicity Assessment (13 papers), DNA Repair Mechanisms (7 papers) and Plant Genetic and Mutation Studies (4 papers). Verne A. Ray is often cited by papers focused on Carcinogens and Genotoxicity Assessment (13 papers), DNA Repair Mechanisms (7 papers) and Plant Genetic and Mutation Studies (4 papers). Verne A. Ray collaborates with scholars based in United States, Canada and United Kingdom. Verne A. Ray's co-authors include David E. Amacher, Simone C. Paillet, Virginia C. Dunkel, David Brusick, Vincent F. Simmon, Martha L. Hyneck, Angela E. Auletta, Henry E. Holden, David S. Salsburg and Joyce McCann and has published in prestigious journals such as Journal of Bacteriology, Environmental Health Perspectives and Annals of the New York Academy of Sciences.

In The Last Decade

Verne A. Ray

27 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verne A. Ray United States 15 577 393 237 233 74 27 935
Angela E. Auletta United States 15 735 1.3× 361 0.9× 378 1.6× 322 1.4× 92 1.2× 29 1.1k
Gregory S. Probst United States 17 641 1.1× 433 1.1× 292 1.2× 437 1.9× 55 0.7× 31 1.2k
Rudolf Fahrig Germany 20 529 0.9× 525 1.3× 269 1.1× 160 0.7× 76 1.0× 53 978
Hiroyasu Shimada Japan 21 720 1.2× 670 1.7× 341 1.4× 401 1.7× 62 0.8× 46 1.6k
A.S. Wright United Kingdom 17 292 0.5× 180 0.5× 159 0.7× 190 0.8× 50 0.7× 37 684
J.P. Seiler Switzerland 18 496 0.9× 299 0.8× 351 1.5× 317 1.4× 89 1.2× 52 1.1k
David Tweats United Kingdom 20 492 0.9× 375 1.0× 203 0.9× 228 1.0× 48 0.6× 45 1.2k
Edward S. Riccio United States 18 297 0.5× 191 0.5× 99 0.4× 177 0.8× 72 1.0× 30 643
Peter Kasper Germany 19 714 1.2× 428 1.1× 299 1.3× 390 1.7× 66 0.9× 42 1.1k
Gary M. Decad United States 11 239 0.4× 331 0.8× 96 0.4× 217 0.9× 46 0.6× 12 862

Countries citing papers authored by Verne A. Ray

Since Specialization
Citations

This map shows the geographic impact of Verne A. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verne A. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verne A. Ray more than expected).

Fields of papers citing papers by Verne A. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verne A. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verne A. Ray. The network helps show where Verne A. Ray may publish in the future.

Co-authorship network of co-authors of Verne A. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Verne A. Ray. A scholar is included among the top collaborators of Verne A. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verne A. Ray. Verne A. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Amacher, David E., et al.. (1993). Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. Mutation Research/Genetic Toxicology. 300(2). 79–90. 16 indexed citations
3.
Al-Maghtheh, Mai, et al.. (1993). Variation in DNA Polymorphisms of the Short Arm of the Human X Chromosome: Genetic Affinity of Parsi from Western India. Human Heredity. 43(4). 239–243. 3 indexed citations
5.
Williams, Gary M., Virginia C. Dunkel, & Verne A. Ray. (1983). Cellular systems for toxicity testing.. PubMed. 407. 1–484. 60 indexed citations
6.
Ray, Verne A.. (1983). RELEVANCY ISSUES. Annals of the New York Academy of Sciences. 407(1). 362–366. 2 indexed citations
7.
Ray, Verne A.. (1982). Approaches to the Genetic Safety Evalution of Agricultural Chemicals. 45–56. 4 indexed citations
8.
Amacher, David E., Simone C. Paillet, Gail N. Turner, Verne A. Ray, & David S. Salsburg. (1980). Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells II. Test validation and interpretation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 72(3). 447–474. 90 indexed citations
9.
Amacher, David E., Simone C. Paillet, & Verne A. Ray. (1979). Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. Mutation Research/Environmental Mutagenesis and Related Subjects. 64(6). 391–406. 79 indexed citations
10.
Ray, Verne A., et al.. (1975). Point mutation assays using bacterial indicators. Mutation Research/Environmental Mutagenesis and Related Subjects. 31(5). 310–310. 1 indexed citations
11.
Ray, Verne A., et al.. (1975). dd -Carboxypeptidase and Peptidoglycan Transpeptidase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 7(5). 578–581. 8 indexed citations
12.
Holden, Henry E., et al.. (1975). A comparative study of Schistosomicides in cytogenetic and point mutation assays. Mutation Research/Environmental Mutagenesis and Related Subjects. 31(5). 309–310. 4 indexed citations
13.
Ray, Verne A., et al.. (1974). Comparative studies of ethyl methanesulfonate-induced mutations with host-mediated, dominant lethal, and cytogenetic assays. Toxicology and Applied Pharmacology. 30(1). 107–116. 13 indexed citations
14.
Ray, Verne A., Henry E. Holden, John Ellis, & Martha L. Hyneck. (1973). A study of triflupromazine in dominant-lethal, cytogenetic and host-mediated assays. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 18(3). 301–309. 15 indexed citations
15.
Holden, Henry E., et al.. (1973). Mutagenicity studies with 6-mercaptopurine: I. Cytogenetic activity in vivo. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 20(2). 257–263. 28 indexed citations
16.
Ray, Verne A. & Martha L. Hyneck. (1973). Some primary considerations in the interpretation of the dominant-lethal assay.. Environmental Health Perspectives. 6. 27–35. 21 indexed citations
17.
Ray, Verne A.. (1973). Summary of Panel on the Dominant-Lethal Test. Environmental Health Perspectives. 6. 65–65. 2 indexed citations
18.
Ray, Verne A. & Martha L. Hyneck. (1973). Some Primary Considerations in the Interpretation of the Dominant-Lethal Assay. Environmental Health Perspectives. 6. 27–27. 4 indexed citations
19.
Retsema, James A. & Verne A. Ray. (1972). Correlation Between the Binding of β-Lactam Antibiotics to Staphylococcus aureus and Their Physical-Chemical Properties. Antimicrobial Agents and Chemotherapy. 2(3). 173–180. 4 indexed citations
20.
Ray, Verne A.. (1960). Mutant induction during the divisional cycle in bacteria.. 20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026